Aims and Scope of Journal of Medical Economics
The Journal of Medical Economics is a monthly peer-reviewed academic journal that covers econometric assessments of novel therapeutic and medical device interventions. It is published by Routledge and was established in 1998. The editor-in-chief is K. Lee. Less
Key Metrics
CiteScore 

3.7
H-Index 

52
Impact Factor 

< 5
SJR 

Q2Health Policy

SNIP 

0.86
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Medical Economics
Journal of Medical Economics Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1991 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Medical Economics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Medical Economics
Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumors
- 31 Dec 2026
- Journal of Medical Economics
Cost per responder analysis of iptacopan versus eculizumab and ravulizumab in treatment of paroxysmal nocturnal hemoglobinuria: implications for decision-making
- 31 Dec 2026
- Journal of Medical Economics
Health state utilities for relapsed or refractory large B-cell lymphoma treatments: a time trade-off study in the Japanese general population
- 31 Dec 2026
- Journal of Medical Economics
Impact of offering blood-based testing alongside existing modalities for colorectal cancer screening among those who previously declined screening: an economic evaluation
- 31 Dec 2026
- Journal of Medical Economics
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with sickle cell disease with recurrent vaso-occlusive crises in the United States
- 31 Dec 2026
- Journal of Medical Economics
The economic burden of moderate-to-severe rheumatoid arthritis in Spain: the CIARA study
- 31 Dec 2026
- Journal of Medical Economics
Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumors
- 31 Dec 2026
- Journal of Medical Economics
Cost per responder analysis of iptacopan versus eculizumab and ravulizumab in treatment of paroxysmal nocturnal hemoglobinuria: implications for decision-making
- 31 Dec 2026
- Journal of Medical Economics
Health state utilities for relapsed or refractory large B-cell lymphoma treatments: a time trade-off study in the Japanese general population
- 31 Dec 2026
- Journal of Medical Economics
Impact of offering blood-based testing alongside existing modalities for colorectal cancer screening among those who previously declined screening: an economic evaluation
- 31 Dec 2026
- Journal of Medical Economics
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with sickle cell disease with recurrent vaso-occlusive crises in the United States
- 31 Dec 2026
- Journal of Medical Economics
The economic burden of moderate-to-severe rheumatoid arthritis in Spain: the CIARA study
- 31 Dec 2026
- Journal of Medical Economics